Journal ArticleDOI
Intensity-modulated radiation therapy for orbital lymphoma
TLDR
IMRT is feasible when treating orbital lymphoma and reduces dose to critical structures while providing excellent dose coverage of target volumes, similar to conventional RT, with no increased toxicity.Abstract:
Purpose
Orbital manifestations of non-Hodgkin’s lymphoma (NHL) are rare and accounts for only 1% of all cases of NHL. There have been no reports of treating orbital lymphoma using intensity-modulated radiotherapy (IMRT).read more
Citations
More filters
Journal ArticleDOI
Ocular Risks From Orbital and Periorbital Radiation Therapy: A Critical Review
TL;DR: An overview of the potential complications of orbital radiotherapy and recommendations for the management of RTrelated toxicities are discussed.
Journal ArticleDOI
Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.
Rahul R. Parikh,Bruce K. Moskowitz,Elizabeth Maher,David Della Rocca,Robert C. Della Rocca,Bruce Culliney,Ilan Shapira,Michael L. Grossbard,Louis B. Harrison,Kenneth S. Hu +9 more
TL;DR: Definitive RT to 30 Gy was shown to be highly effective for indolent OL, and this study represents one of the largest single-institution studies using primary RT for stage IE OL.
Journal ArticleDOI
CyberKnife radiosurgery for the treatment of intraocular and periocular lymphoma.
TL;DR: CyberKnife radiosurgery is a well-tolerated technique for the treatment of intraocular and periocular lymphoma, allowing for local resolution of the lesions.
Journal ArticleDOI
Extranodal Marginal Zone Lymphoma of Ocular Adnexa: Outcomes following Radiation Therapy.
TL;DR: It is confirmed that radiation therapy (median 25 Gy) for extranodal marginal zone lymphoma of the ocular adnexa is associated with high local control and low risk of visually significant complications.
Journal ArticleDOI
Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy
Robert F. Hobbs,Sébastien Baechler,Richard L. Wahl,Bin He,Hong Song,Caroline Esaias,Eric C. Frey,Heather A. Jacene,George Sgouros +8 more
TL;DR: The dosimetry analysis suggested that arterial wall toxicity is highly unlikely in standard dose radioimmunotherapy but should be considered a potential concern and limiting factor in myeloablative therapy.
References
More filters
Journal ArticleDOI
Curative radiotherapy for primary orbital lymphoma.
TL;DR: Radiotherapy alone is a highly effective modality in the curative management of primary orbital lymphoma and the use of the lens-sparing technique did not influence the incidence of cataractogenesis, and it is recommended to recommend this approach whenever possible.
Journal ArticleDOI
Radiotherapy in the management of orbital lymphoma.
Timothy W. Bolek,H.Michael Moyses,Robert B. Marcus,Lemuel Gorden,Russell L. Maiese,Nidal M. Almasri,Nancy P. Mendenhall +6 more
TL;DR: Radiotherapy is a safe and effective local treatment in the management of orbital lymphoma and control of disease in the orbit was achieved in all but 1 patient, who developed an out-of-field recurrence after irradiation of a lacrimal tumor and was salvaged with further radiotherapy.
Journal ArticleDOI
Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy
Sylvie Martinet,Mahmut Ozsahin,Yazid Belkacemi,Christine Landmann,Philip Poortmans,Christoph Oehlere,Luciano Scandolaro,Marco Krengli,Philippe Maingon,Raymond Miralbell,Gabriela Studer,Bruno Chauvet,Simone Marnitz,Abderrahim Zouhair,René O. Mirimanoff +14 more
TL;DR: Moderate- to low-dose RT alone is able to control primary orbital lymphoma with low morbidity and prognostic factors were identified that could be useful in the overall management of this uncommon site of primary lymphoma.
Journal ArticleDOI
A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas
TL;DR: Primary orbital lymphoma is an indolent, usually stage I disease, showing low to intermediate-grade histology, and after biopsy the best treatment is 30 (low-grade) to 40 Gy (intermediate- grade) carefully planned, lens-sparing megavoltage radiation without adjuvant chemotherapy.
Journal ArticleDOI
Lymphoreticular tumors of the orbit.
P.J. Fitzpatrick,Sharon Macko +1 more
TL;DR: In the 8 patients with secondary malignant lymphoma, the orbital disease was controlled by irradiation, although all patients required further treatment and died of their disease, and in the 5 and 10 year cause specific actuarial survival rates were 70 and 62%.